Logo
B

Benitec Biopharma

16 employees

Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Rare disease
Patented gene-silencing technology for human disease
Health Diagnostics
Gene therapy
Genetics
Medical

Date founded

2001

Funding rounds raised

Total raised

$3M

from 2 investors over 2 rounds

B

Benitec Biopharma raised $3M on August 11, 2023

Investors: Adage Capital Management and Suvretta Capital Management LLC

FAQ